Last update:

Weight management news

Engineers use AI, Reddit to identify potential side effects of unapproved new GLP-1

Retatrutide, a next-generation GLP-1 weight-loss drug, is not yet approved for use. Nevertheless, online forums reveal that people are purchasing unapproved versions of the drug, which are not intended for human consumption, ...

Study finds a lower cancer risk after obesity surgery regardless of age or sex

Bariatric surgery reduces the risk of obesity-related cancer regardless of sex and age, according to a large Nordic registry study led by researchers at Karolinska Institutet. The results, published in JAMA Surgery, strengthen ...

How many daily steps do you need to lose weight?

Staying active is key to staying healthy, and fitness trackers and smartwatches have become popular tools for tracking activity. But just how many steps does someone need to take each day to lose weight? Experts say there's ...

Understanding adult obesity

Obesity is one of the most common health conditions in the world and one of the most misunderstood. Today, it affects about 4 in 10 U.S. adults, and the numbers keep rising.

Body mass index: It's not all that it's hyped up to be

Body mass index (BMI) is a simple mathematical formula widely used to quickly gauge someone's health. BMI = weight (kg) divided by height squared (m2). Its simplicity and cost-effectiveness makes BMI a popular health tool, ...

Abdominal obesity may lead to more severe menopause symptoms

Weight gain during menopause is common, with abdominal obesity being especially common and unhealthy. A new study based on data from the Study of Women's Health Across the Nation (SWAN) has found that in addition to its adverse ...

The critical role of exercise in the GLP-1 era

As GLP-1 receptor agonists reshape obesity treatment, a new medical perspective published in JAMA, underscores a persistent gap in care: integrating exercise into weight management in ways patients can sustain.

Gut hormone FGF15 changes how mice respond to weight loss

Nearly 40% of the population in the United States develop obesity, which is linked to the development of several diseases, including type 2 diabetes and metabolic liver disease. The rise in obesity is, in part, caused by ...

The GLP-1 paradox: Weight loss drugs may lead to stigma

Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs ...